Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Intevac, Inc. (IVAC) A Good Stock To Buy?

Page 1 of 2

Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities over the years (that’s why their assets under management continue to swell). We believe hedge fund sentiment should serve as a crucial tool of an individual investor’s stock selection process, as it may offer great insights of how the brightest minds of the finance industry feel about specific stocks. After all, these people have access to smartest analysts and expensive data/information sources that individual investors can’t match. So should one consider investing in Intevac, Inc. (NASDAQ:IVAC)? The smart money sentiment can provide an answer to this question.

Intevac, Inc. (NASDAQ:IVAC) has seen a slight decrease in hedge fund sentiment in recent months with 8 funds holding shares at the end of September, down by one over the quarter. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as SCYNEXIS Inc (NASDAQ:SCYX), Lakeland Industries, Inc. (NASDAQ:LAKE), and Nicholas Financial, Inc. (NASDAQ:NICK) to gather more data points.

Follow Intevac Inc (NASDAQ:IVAC)
Trade (NASDAQ:IVAC) Now!

To most market participants, hedge funds are viewed as slow, outdated financial tools of the past. While there are more than an 8000 funds with their doors open at present, we look at the masters of this club, approximately 700 funds. It is estimated that this group of investors oversees the lion’s share of all hedge funds’ total capital, and by following their best picks, Insider Monkey has revealed several investment strategies that have historically outperformed the S&P 500 index. Insider Monkey’s small-cap hedge fund strategy surpassed the S&P 500 index by 12 percentage points per year for a decade in their back tests.

Keeping this in mind, let’s take a glance at the latest action surrounding Intevac, Inc. (NASDAQ:IVAC).

What have hedge funds been doing with Intevac, Inc. (NASDAQ:IVAC)?

At the Q3’s end, a total of 7 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of -13% from the previous quarter. With hedgies’ positions undergoing their usual ebb and flow, there exists a few notable hedge fund managers who were boosting their stakes significantly (or already accumulated large positions).

Of the funds tracked by Insider Monkey, Matthew Drapkin and Steven R. Becker’s Becker Drapkin Management has the largest position in Intevac, Inc. (NASDAQ:IVAC), worth close to $10.4 million, accounting for 11.6% of its total 13F portfolio. The second largest stake is held by Royce & Associates, managed by Chuck Royce, which holds an $8.2 million position; less than 0.1%% of its 13F portfolio is allocated to the company. Remaining members of the smart money that are bullish contain Jim Simons’s Renaissance Technologies, Israel Englander’s Millennium Management and John Overdeck and David Siegel’s Two Sigma Advisors.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!